Norihiko Kumada

Suggest Changes

Writes About:

Learn More
INTRODUCTION This study describes our clinical experience of late conversion from antimetabolites with standard exposure calcineurin inhibitors (CNIs) to everolimus with CNI minimization in stable(More)